You searched for "scarring"
Squamous metaplasia of conjunctival epithelial cells with soft contact lens wear versus non-lens wearers
Conjunctiva is composed of non-squamous epithelial cells interspersed with goblet cells, which is a secretory epithelium. Squamous metaplasia is a transformation to non-secretory epithelium, ‘keratinised’ and enlargement of the conjunctival non-goblet cells and relatively shrunken nuclei are seen on impression...
Are corneal guttata an additional risk factor in complicated cataract surgery needing a future corneal transplant?
This registry-based cohort study from Sweden utilised data from the Swedish National Cataract Registry and the Swedish Cornea Transplant Registry. Patients who underwent phacoemulsification with a posterior intraocular lens between 2010 and 2012 numbered 192,476. Of these cases, 288 underwent...
Medial rectus anatomy in exotropia
This study investigates the differences between extraocular muscles in patients with intermittent exotropia and normal controls regarding muscle fibre arrangement and diameter, and distribution and activation of satellite cells. Fifteen patients were recruited having medial rectus resection surgery. Resection sections...
Does lower eyelid entropion repair alter corneal topography?
The authors aimed to analyse the corneal morphology before and after advancement of posterior lower eyelid retractors (LERs) alone or in combination with a lateral tarsal strip (LTS) for lower eyelid involutional entropion. Retrospective analysis of 24 consecutive elderly patients...Assessing everyday visual function in dry AMD – what matters to the person?
1 April 2019
| Bethany E Higgins, Deanna J Taylor, David P Crabb (Prof)
|
EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is the primary cause of blindness in the developed world and is accountable for more than one half of sight impairment registrations within England and Wales [1]. AMD is prevalent in people aged 60 years and...
Young visionaries win global competition by re-designing the Glasses of the Future
The International Agency for the Prevention of Blindness (IAPB) celebrated UNICEF World Children’s Day by announcing the winners of ‘Glasses of the Future’, a global competition that invited children across the world to design the next generation of glasses. Lama...Recurrent corneal erosions secondary to isotretinoin use
Isotretinoin (13–cis-retinoic acid) is the first line treatment for moderate to severe nodulocystic or papulopustular acne [1,2]. Although it is a safe medication, it has several adverse side-effects, including ophthalmic manifestations, as shown in Table 1 [3]. These side-effects need...Moorfields Eye Charity’s six-year growth and impact
Moorfields Eye Charity launches its impact report showing that it has grown to become the leading charity in the UK funding research into eye health and innovation and improvement in patient care.Redeployment during the COVID-19 pandemic: personal accounts from four ophthalmology trainees
5 August 2020
| Nada Burgess, Mary Henry, Maria Tadros, Yu Jeat Chong
|
EYE - General
We once believed that the coronavirus would not penetrate the safe confines of the United Kingdom, like so many outbreaks before this. Once the news came that this pandemic descended into our hospitals, the anxieties about redeployment began. Many of...
Strengthening eye care services in Botswana through the Botswana-Addenbrooke’s Abroad VISION 2020 LINK
1 April 2016
| Evelyn Brealey, Alice Lehasa, Malcolm Kerr-Muir, Marcia Zondervan
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
The VISION 2020 LINK between Botswana and Addenbrooke’s Abroad has been running for 10 years. With support from the VISION 2020 LINKS Programme two-way exchange visits were undertaken leading to the formation of the first formal international partnership under Addenbrooke’s...
Effective treatment for rare sight-threatening infection
A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.There will be a 27% rise in the number of people living with sight loss in the UK by 2035, RNIB the UK’s leading sight loss charity predicts
20 October 2024
|
charity, international, government, call to action, UK, local, sight loss, statistics
This World Sight Day, leading sight loss charity the Royal National Institute of Blind People (RNIB) was calling for the UK Government to prioritise eye health. This is after fresh insight from the charity that shows there will be a...
